Log In
Print
BCIQ
Print
Print this Print this
 

INV-17

  Manage Alerts
Collapse Summary General Information
Company Innovimmune Biotherapeutics Inc.
DescriptionOral small molecule RAR-related orphan receptor C thymus-specific isoform (RORgamma2; RORgammaT) inverse agonist
Molecular Target RAR-related orphan receptor C thymus-specific isoform (RORgamma2) (RORgammaT)
Mechanism of Action 
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today